Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

High cumulative JC virus seroconversion rate during long-term use of natalizumab.
Bioenergetics of the spinal cord in experimental autoimmune encephalitis of rats.
S1P1 localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity.
Glia in mammalian development and disease.
Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis.
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS.
Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk.
Interest in providing multiple sclerosis care and subspecializing in multiple sclerosis among neurology residents.
Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study.
Comparison of the effect of baclofen and transcutaneous electrical nerve stimulation for the treatment of spasticity in multiple sclerosis.
Natalizumab (BG00002) Re-Initiation of Dosing. (STRATA)
No evidence for CCVSI in relapsing-remitting multiple sclerosis patients with moderate disability.
Ginkgo biloba does not improve cognitive function in MS: A randomized placebo-controlled trial.
Corrigendum: "High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II - The Total Macular Volume. The First Follow-Up Study Over 2 Years".
Abnormal control of orbicularis oculi reflex excitability in multiple sclerosis.
Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.
Neuroprotective effects of chrysin: From chemistry to medicine.
Neuromyelitis optica.
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.
Unusual symptoms and syndromes in multiple sclerosis.
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial.
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
Mitochondrial and nuclear genes as the cause of complex I deficiency.
Vagus somatosensory-evoked potentials are prolonged in patients with multiple sclerosis with brainstem involvement.

Pages